What constitutes disease modification in IgA nephropathy? [PDF]
Clin Kidney JTsuboi N, Hotta O.
europepmc +1 more source
The Three Faces of IgA Nephropathy: Clinicopathological Heterogeneity and Urinary Albumin-to-Protein Ratio in a Case Series. [PDF]
J Clin MedMasajtis-Zagajewska A +2 more
europepmc +1 more source
Time to diabetic nephropathy and its predictors among adult diabetic patients at public general and referral hospitals in South Wollo Zone, Northeast Ethiopia: A retrospective follow up study. [PDF]
SAGE Open MedWorku T, Mohammed A, Andargie EM.
europepmc +1 more source
Statement of Retraction: Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy. [PDF]
Bioengineeredeuropepmc +1 more source
Practice Variation in IgA Nephropathy: When the Field Evolves Faster Than Consensus. [PDF]
Kidney360Vasquez-Rios G, Sanchez-Russo L.
europepmc +1 more source
Statement of Retraction: Salvianolic Acid B Attenuates Membranous Nephropathy by Activating Renal Autophagy via MicroRNA-145-5p/Phosphatidylinositol 3-kinase/AKT Pathway. [PDF]
Bioengineeredeuropepmc +1 more source
Metformin protects podocytes by inhibiting the MAPK14-SLC7A11-GPX4 axis and dysregulation of fatty acid metabolism. [PDF]
DiabetologiaQiu S +13 more
europepmc +1 more source
Statement of Retraction: Mitogen-activating protein kinase kinase kinase kinase-3, inhibited by Astragaloside IV through H3 lysine 4 monomethylation, promotes the progression of diabetic nephropathy by inducing apoptosis. [PDF]
Bioengineeredeuropepmc +1 more source
Disulfiram Attenuates Adenine-Induced Renal Fibrosis by Modulating Inflammatory and Immunometabolic Responses. [PDF]
FASEB JKin S +5 more
europepmc +1 more source